首页> 外国专利> clonidine and / or clonidine derivatives for use in the prevention and / or treatment of chemotherapy adverse side effects

clonidine and / or clonidine derivatives for use in the prevention and / or treatment of chemotherapy adverse side effects

机译:可乐定和/或可乐定衍生物用于预防和/或治疗化学疗法的不良副作用

摘要

The present invention relates to clonidine and / or specific clonidine derivatives for use in the prevention and / or treatment of adverse chemotherapy side effects of alkylating agents other than those resulting from mucosal inflammation. It also relates to the use of this clonidine and / or clonidine derivative for the manufacture of a pharmaceutical composition intended to prevent and / or alleviate the adverse side effects of chemotherapy of alkylating agents, other than those resulting from mucosal inflammation. This invention is further directed to a kit comprising: (a) a clonidine and / or a clonidine derivative, and (b) at least one chemotherapeutic alkylating agent as a combined preparation for simultaneous, separate or sequential use in the treatment of cancer. .
机译:可乐定和/或特定的可乐定衍生物本发明涉及可乐定和/或特定的可乐定衍生物,该可乐定和/或特定的可乐定衍生物用于预防和/或治疗由粘膜炎症引起的烷化剂以外的烷化剂的不良化学疗法副作用。它还涉及该可乐定和/或可乐定衍生物在制备药物组合物中的用途,所述药物组合物旨在预防和/或减轻烷基化剂化学疗法的不良副作用,而不是由粘膜炎症引起的副作用。本发明进一步涉及一种试剂盒,其包含:(a)可乐定和/或可乐定衍生物,和(b)至少一种化学治疗性烷基化剂作为组合制剂,用于同时,分别或依次用于治疗癌症。 。

著录项

  • 公开/公告号BR112017022321A2

    专利类型

  • 公开/公告日2018-07-03

    原文格式PDF

  • 申请/专利权人 MONOPAR THERAPEUTICS INC.;

    申请/专利号BR20171122321

  • 发明设计人 BÉRANGÈRE VASSEUR-DEMARCY;PIERRE ATTALI;

    申请日2015-04-17

  • 分类号A61K31/4168;A61P1/08;

  • 国家 BR

  • 入库时间 2022-08-21 12:53:40

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号